Data availability
The PET data that support the findings are available from the corresponding author upon reasonable request.
References
Tirelli U, Chierichetti F, Tavio M, Simonelli C, Bianchin G, Zanco P, et al. Brain positron emission tomography (PET) in chronic fatigue syndrome: preliminary data. Am J Med. 1998;105:54S–8S. https://doi.org/10.1016/s0002-9343(98)00179-x.
Siessmeier T, Nix WA, Hardt J, Schreckenberger M, Egle UT, Bartenstein P. Observer independent analysis of cerebral glucose metabolism in patients with chronic fatigue syndrome. J Neurol Neurosurg Psychiatry. 2003;74:922–8. https://doi.org/10.1136/jnnp.74.7.922.
Sahbai S, Kauv P, Abrivard M, Blanc-Durand P, Aoun-Sebati M, Emsen B, et al. Severe posterior hypometabolism but normal perfusion in a patient with chronic fatigue syndrome/myalgic encephalomyelitis revealed by PET/MRI. Eur J Nucl Med Mol Imaging. 2019;46:531–2. https://doi.org/10.1007/s00259-018-4229-3.
Efrati S, Golan H, Bechor Y, Faran Y, Daphna-Tekoah S, Sekler G, et al. Hyperbaric oxygen therapy can diminish fibromyalgia syndrome--prospective clinical trial. PLoS One. 2015;10:e0127012. https://doi.org/10.1371/journal.pone.0127012.
Akarsu S, Tekin L, Ay H, Carli AB, Tok F, Simşek K, et al. The efficacy of hyperbaric oxygen therapy in the management of chronic fatigue syndrome. Undersea Hyperb Med. 2013;40:197–200.
Yildiz S, Uzun G, Kiralp MZ. Hyperbaric oxygen therapy in chronic pain management. Curr Pain Headache Rep. 2006;10:95–100. https://doi.org/10.1007/s11916-006-0019-x.
Hui J, Zhang ZJ, Zhang X, Shen Y, Gao YJ. Repetitive hyperbaric oxygen treatment attenuates complete Freund's adjuvant-induced pain and reduces glia-mediated neuroinflammation in the spinal cord. J Pain. 2013;14:747–58. https://doi.org/10.1016/j.jpain.2013.02.003.
Guedj E, Cammilleri S, Niboyet J, Dupont P, Vidal E, Dropinski JP, et al. Clinical correlate of brain SPECT perfusion abnormalities in fibromyalgia. J Nucl Med. 2008;49:1798–803. https://doi.org/10.2967/jnumed.108.053264.
Funding
The local PET database of healthy controls was funded by APHM (regional PHRC; NCT00484523).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethics approval
The case report is a retrospective observation with no ethical approval requirement other than the informed written consent.
The local PET database of healthy controls was acquired in accordance with the Declaration of Helsinki, with informed written consent of patients and approval from “CPP Sud Méditerranée V” ethics committee.
Consent to participate
Informed written consent was obtained from all individual participants included in the study.
Consent for publication
Informed written consent was obtained from all individual participants included in the study.
Code availability
Not applicable.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
This article is part of the Topical Collection on Neurology
Rights and permissions
About this article
Cite this article
Mairal, E., Barberon, B., Laine, N. et al. Reversible widespread brain 18F-FDG PET hypometabolism in chronic fatigue syndrome treated by hyperbaric oxygen therapy. Eur J Nucl Med Mol Imaging 48, 1680–1681 (2021). https://doi.org/10.1007/s00259-020-05122-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00259-020-05122-0